Asset Details
Do you wish to reserve the book?
The Making of an Entrepreneurial Science: Biotechnology in Britain, 1975–1995
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Making of an Entrepreneurial Science: Biotechnology in Britain, 1975–1995
Do you wish to request the book?
The Making of an Entrepreneurial Science: Biotechnology in Britain, 1975–1995
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Making of an Entrepreneurial Science: Biotechnology in Britain, 1975–1995
2011
Overview
Monoclonal antibodies played a key role in the development of the biotechnology industry of the 1980s and 1990s. Investments in the sector and commercial returns have rivaled those of recombinant DNA technologies. Although the monoclonal antibody technology was first developed in Britain, the first patents were taken out by American scientists. During the first Thatcher government in Britain, blame for the missed opportunity fell on the scientists involved as well as on the National Research and Development Corporation, which had been put in place after World War II to avoid a repeat of the penicillin story, when patent rights were not sought. Instead of apportioning the blame, this essay suggests that despite past experiences and despite the new channels that were in place, Britain was not in a “patent culture” in the 1970s. It traces the long and painful process that made a commercial attitude among publicly funded British research scientists and in a civil service institution like the Medical Research Council both possible and desirable. In this process the meaning of the term “public science” also changed dramatically.
Publisher
University of Chicago Press,University of Chicago, acting through its Press
Subject
/ Antibodies, Monoclonal - economics
/ Antibodies, Monoclonal - history
/ Biology
/ Biomedical Research - economics
/ Biomedical Research - history
/ Biomedical Research - legislation & jurisprudence
/ Biotechnology - legislation & jurisprudence
/ Blame
/ Commerce - legislation & jurisprudence
/ DNA
/ History of science and technology
/ Humans
/ R&D
/ Science
